• レポートコード:MRC2312MG03797 • 出版社/出版日:Market Monitor Global / 2023年12月 • レポート形態:英文、PDF、68ページ • 納品方法:Eメール(納期:3営業日) • 産業分類:医療 |
Single User | ¥487,500 (USD3,250) | ▷ お問い合わせ |
Enterprise User | ¥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートは次の情報を含め、世界のゲノム(DNA)シーケンス市場規模と予測を収録しています。・世界のゲノム(DNA)シーケンス市場:売上、2018年-2023年、2024年-2029年 ・世界のゲノム(DNA)シーケンス市場:販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のゲノム(DNA)シーケンス市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「次世代シーケンシング」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ゲノム(DNA)シーケンスのグローバル主要企業は、Agilent Technologies Inc.、 BGI、 Bio-Rad Laboratories、 Danaher、 F. Hoffmann-La Roche Ltd.、 Genome Electric Company、 Illumina Inc.、 IntegraGen、 Oxford Nanopore Technologies、 Pacific Biosciences of California Inc.、 QIAGEN、 Thermo Fisher Scientific Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL(MMG)は、ゲノム(DNA)シーケンスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のゲノム(DNA)シーケンス市場:タイプ別、2018年-2023年、2024年-2029年 世界のゲノム(DNA)シーケンス市場:タイプ別市場シェア、2022年 ・次世代シーケンシング、第三世代DNAシーケンシング、その他 世界のゲノム(DNA)シーケンス市場:用途別、2018年-2023年、2024年-2029年 世界のゲノム(DNA)シーケンス市場:用途別市場シェア、2022年 ・研究機関、製薬&バイオテクノロジー企業、医療施設&診断センター 世界のゲノム(DNA)シーケンス市場:地域・国別、2018年-2023年、2024年-2029年 世界のゲノム(DNA)シーケンス市場:地域別市場シェア、2022年 ・北米:アメリカ、カナダ、メキシコ ・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア ・アジア:中国、日本、韓国、東南アジア、インド ・南米:ブラジル、アルゼンチン ・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるゲノム(DNA)シーケンスのグローバル売上、2018年-2023年 ・主要企業におけるゲノム(DNA)シーケンスのグローバル売上シェア、2022年 ・主要企業におけるゲノム(DNA)シーケンスのグローバル販売量、2018年-2023年 ・主要企業におけるゲノム(DNA)シーケンスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Agilent Technologies Inc.、 BGI、 Bio-Rad Laboratories、 Danaher、 F. Hoffmann-La Roche Ltd.、 Genome Electric Company、 Illumina Inc.、 IntegraGen、 Oxford Nanopore Technologies、 Pacific Biosciences of California Inc.、 QIAGEN、 Thermo Fisher Scientific Inc. ************************************************************* ・調査・分析レポートの概要 ゲノム(DNA)シーケンス市場の定義 市場セグメント 世界のゲノム(DNA)シーケンス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のゲノム(DNA)シーケンス市場規模 世界のゲノム(DNA)シーケンス市場規模:2022年 VS 2029年 世界のゲノム(DNA)シーケンス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのゲノム(DNA)シーケンスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のゲノム(DNA)シーケンス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分:次世代シーケンシング、第三世代DNAシーケンシング、その他 ゲノム(DNA)シーケンスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分:研究機関、製薬&バイオテクノロジー企業、医療施設&診断センター ゲノム(DNA)シーケンスの用途別グローバル売上・予測 ・地域別市場分析 地域別ゲノム(DNA)シーケンス市場規模 2022年と2029年 地域別ゲノム(DNA)シーケンス売上・予測 北米市場:アメリカ、カナダ、メキシコ ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア アジア市場:中国、日本、韓国、東南アジア、インド 南米市場:ブラジル、アルゼンチン 中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど) Agilent Technologies Inc.、 BGI、 Bio-Rad Laboratories、 Danaher、 F. Hoffmann-La Roche Ltd.、 Genome Electric Company、 Illumina Inc.、 IntegraGen、 Oxford Nanopore Technologies、 Pacific Biosciences of California Inc.、 QIAGEN、 Thermo Fisher Scientific Inc. ... |
This research report provides a comprehensive analysis of the Genome (DNA) Sequencing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Genome (DNA) Sequencing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Genome (DNA) Sequencing, challenges faced by the industry, and potential opportunities for market players.
The global Genome (DNA) Sequencing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Genome (DNA) Sequencing market presents opportunities for various stakeholders, including Research Institutes, Pharmaceutical & Biotechnological Companies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Genome (DNA) Sequencing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Genome (DNA) Sequencing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Genome (DNA) Sequencing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Genome (DNA) Sequencing market.
Market Overview: The report provides a comprehensive overview of the Genome (DNA) Sequencing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Next-Generation Sequencing, Third Generation DNA Sequencing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Genome (DNA) Sequencing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Genome (DNA) Sequencing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Genome (DNA) Sequencing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Genome (DNA) Sequencing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Genome (DNA) Sequencing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Genome (DNA) Sequencing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Genome (DNA) Sequencing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Genome (DNA) Sequencing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Genome (DNA) Sequencing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
Market segment by Application
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
Global Genome (DNA) Sequencing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genome (DNA) Sequencing, market overview.
Chapter 2: Global Genome (DNA) Sequencing market size in revenue.
Chapter 3: Detailed analysis of Genome (DNA) Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genome (DNA) Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Genome (DNA) Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genome (DNA) Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genome (DNA) Sequencing Overall Market Size
2.1 Global Genome (DNA) Sequencing Market Size: 2022 VS 2029
2.2 Global Genome (DNA) Sequencing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genome (DNA) Sequencing Players in Global Market
3.2 Top Global Genome (DNA) Sequencing Companies Ranked by Revenue
3.3 Global Genome (DNA) Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Genome (DNA) Sequencing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genome (DNA) Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genome (DNA) Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Genome (DNA) Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Genome (DNA) Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Genome (DNA) Sequencing Market Size Markets, 2022 & 2029
4.1.2 Next-Generation Sequencing
4.1.3 Third Generation DNA Sequencing
4.1.4 Others
4.2 By Type – Global Genome (DNA) Sequencing Revenue & Forecasts
4.2.1 By Type – Global Genome (DNA) Sequencing Revenue, 2018-2023
4.2.2 By Type – Global Genome (DNA) Sequencing Revenue, 2024-2029
4.2.3 By Type – Global Genome (DNA) Sequencing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Genome (DNA) Sequencing Market Size, 2022 & 2029
5.1.2 Research Institutes
5.1.3 Pharmaceutical & Biotechnological Companies
5.1.4 Healthcare Facilities & Diagnostic Centres
5.2 By Application – Global Genome (DNA) Sequencing Revenue & Forecasts
5.2.1 By Application – Global Genome (DNA) Sequencing Revenue, 2018-2023
5.2.2 By Application – Global Genome (DNA) Sequencing Revenue, 2024-2029
5.2.3 By Application – Global Genome (DNA) Sequencing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Genome (DNA) Sequencing Market Size, 2022 & 2029
6.2 By Region – Global Genome (DNA) Sequencing Revenue & Forecasts
6.2.1 By Region – Global Genome (DNA) Sequencing Revenue, 2018-2023
6.2.2 By Region – Global Genome (DNA) Sequencing Revenue, 2024-2029
6.2.3 By Region – Global Genome (DNA) Sequencing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Genome (DNA) Sequencing Revenue, 2018-2029
6.3.2 US Genome (DNA) Sequencing Market Size, 2018-2029
6.3.3 Canada Genome (DNA) Sequencing Market Size, 2018-2029
6.3.4 Mexico Genome (DNA) Sequencing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Genome (DNA) Sequencing Revenue, 2018-2029
6.4.2 Germany Genome (DNA) Sequencing Market Size, 2018-2029
6.4.3 France Genome (DNA) Sequencing Market Size, 2018-2029
6.4.4 U.K. Genome (DNA) Sequencing Market Size, 2018-2029
6.4.5 Italy Genome (DNA) Sequencing Market Size, 2018-2029
6.4.6 Russia Genome (DNA) Sequencing Market Size, 2018-2029
6.4.7 Nordic Countries Genome (DNA) Sequencing Market Size, 2018-2029
6.4.8 Benelux Genome (DNA) Sequencing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Genome (DNA) Sequencing Revenue, 2018-2029
6.5.2 China Genome (DNA) Sequencing Market Size, 2018-2029
6.5.3 Japan Genome (DNA) Sequencing Market Size, 2018-2029
6.5.4 South Korea Genome (DNA) Sequencing Market Size, 2018-2029
6.5.5 Southeast Asia Genome (DNA) Sequencing Market Size, 2018-2029
6.5.6 India Genome (DNA) Sequencing Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Genome (DNA) Sequencing Revenue, 2018-2029
6.6.2 Brazil Genome (DNA) Sequencing Market Size, 2018-2029
6.6.3 Argentina Genome (DNA) Sequencing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Genome (DNA) Sequencing Revenue, 2018-2029
6.7.2 Turkey Genome (DNA) Sequencing Market Size, 2018-2029
6.7.3 Israel Genome (DNA) Sequencing Market Size, 2018-2029
6.7.4 Saudi Arabia Genome (DNA) Sequencing Market Size, 2018-2029
6.7.5 UAE Genome (DNA) Sequencing Market Size, 2018-2029
7 Genome (DNA) Sequencing Companies Profiles
7.1 Agilent Technologies Inc.
7.1.1 Agilent Technologies Inc. Company Summary
7.1.2 Agilent Technologies Inc. Business Overview
7.1.3 Agilent Technologies Inc. Genome (DNA) Sequencing Major Product Offerings
7.1.4 Agilent Technologies Inc. Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.1.5 Agilent Technologies Inc. Key News & Latest Developments
7.2 BGI
7.2.1 BGI Company Summary
7.2.2 BGI Business Overview
7.2.3 BGI Genome (DNA) Sequencing Major Product Offerings
7.2.4 BGI Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.2.5 BGI Key News & Latest Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Company Summary
7.3.2 Bio-Rad Laboratories Business Overview
7.3.3 Bio-Rad Laboratories Genome (DNA) Sequencing Major Product Offerings
7.3.4 Bio-Rad Laboratories Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.3.5 Bio-Rad Laboratories Key News & Latest Developments
7.4 Danaher
7.4.1 Danaher Company Summary
7.4.2 Danaher Business Overview
7.4.3 Danaher Genome (DNA) Sequencing Major Product Offerings
7.4.4 Danaher Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.4.5 Danaher Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Genome (DNA) Sequencing Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Genome Electric Company
7.6.1 Genome Electric Company Company Summary
7.6.2 Genome Electric Company Business Overview
7.6.3 Genome Electric Company Genome (DNA) Sequencing Major Product Offerings
7.6.4 Genome Electric Company Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.6.5 Genome Electric Company Key News & Latest Developments
7.7 Illumina Inc.
7.7.1 Illumina Inc. Company Summary
7.7.2 Illumina Inc. Business Overview
7.7.3 Illumina Inc. Genome (DNA) Sequencing Major Product Offerings
7.7.4 Illumina Inc. Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.7.5 Illumina Inc. Key News & Latest Developments
7.8 IntegraGen
7.8.1 IntegraGen Company Summary
7.8.2 IntegraGen Business Overview
7.8.3 IntegraGen Genome (DNA) Sequencing Major Product Offerings
7.8.4 IntegraGen Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.8.5 IntegraGen Key News & Latest Developments
7.9 Oxford Nanopore Technologies
7.9.1 Oxford Nanopore Technologies Company Summary
7.9.2 Oxford Nanopore Technologies Business Overview
7.9.3 Oxford Nanopore Technologies Genome (DNA) Sequencing Major Product Offerings
7.9.4 Oxford Nanopore Technologies Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.9.5 Oxford Nanopore Technologies Key News & Latest Developments
7.10 Pacific Biosciences of California Inc.
7.10.1 Pacific Biosciences of California Inc. Company Summary
7.10.2 Pacific Biosciences of California Inc. Business Overview
7.10.3 Pacific Biosciences of California Inc. Genome (DNA) Sequencing Major Product Offerings
7.10.4 Pacific Biosciences of California Inc. Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.10.5 Pacific Biosciences of California Inc. Key News & Latest Developments
7.11 QIAGEN
7.11.1 QIAGEN Company Summary
7.11.2 QIAGEN Business Overview
7.11.3 QIAGEN Genome (DNA) Sequencing Major Product Offerings
7.11.4 QIAGEN Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.11.5 QIAGEN Key News & Latest Developments
7.12 Thermo Fisher Scientific Inc.
7.12.1 Thermo Fisher Scientific Inc. Company Summary
7.12.2 Thermo Fisher Scientific Inc. Business Overview
7.12.3 Thermo Fisher Scientific Inc. Genome (DNA) Sequencing Major Product Offerings
7.12.4 Thermo Fisher Scientific Inc. Genome (DNA) Sequencing Revenue in Global Market (2018-2023)
7.12.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer